Chronic pain affects millions of adults in the United States, and for many patients, standard pain management approaches do not provide enough relief. Medications, procedures, physical therapy, and lifestyle changes may all play a role, but some pain conditions remain difficult to manage even when a patient is doing everything they have been asked to do.
At KDI Health in Frisco, TX, we offer IV ketamine therapy as an off-label option for carefully selected chronic pain patients. That includes patients with conditions such as complex regional pain syndrome (CRPS), fibromyalgia, neuropathic pain, and other treatment-resistant pain patterns where central nervous system sensitization may be part of the clinical picture.
The first question is not simply, “Can ketamine help chronic pain?” A better question is, “Who may be an appropriate candidate, and what should be considered before treatment begins?”
When Chronic Pain Becomes More Than a Symptom
Chronic pain is not always just a lingering sign of an old injury. In many patients, pain becomes a condition in its own right.
When pain persists beyond the expected healing period, or when the nervous system continues amplifying pain signals even after the original trigger has changed, the body’s pain-processing system may be behaving differently. This is one reason chronic pain can feel confusing and discouraging. A patient may be told that an injury has “healed,” while their pain remains severe, persistent, or disabling.
Central sensitization is one concept clinicians use to describe this kind of amplified pain processing. In central sensitization, the brain and spinal cord become more responsive to pain signals. Pain may feel more intense, spread more easily, or occur in response to stimuli that would not normally be painful.
This does not mean the pain is imagined. It means the nervous system itself may be part of the problem.
Why Ketamine Is Considered for Certain Chronic Pain Conditions
Ketamine works differently from many conventional pain medications.
Its best-known mechanism is NMDA receptor antagonism. NMDA receptors are involved in glutamate signaling, pain transmission, and central sensitization. By affecting NMDA receptor activity, ketamine may help interrupt some of the amplified pain signaling that can occur in certain chronic pain states.
That mechanism is one reason ketamine has received research attention for conditions such as CRPS, neuropathic pain, and fibromyalgia. To learn more about how ketamine is used across these conditions, see our overview of ketamine therapy for relief. It is also why ketamine is not simply another version of an opioid, NSAID, or nerve medication.
Ketamine for chronic pain is used off-label. It is not FDA-approved specifically for CRPS, fibromyalgia, neuropathic pain, or other chronic pain diagnoses. Off-label use can still be clinically appropriate in selected cases, but it requires careful screening, informed consent, realistic expectations, and medical supervision.
CRPS and Ketamine Candidacy
Complex regional pain syndrome is one of the chronic pain conditions where ketamine has received particular attention.
CRPS often involves severe, persistent pain in a limb, typically after an injury, surgery, or other precipitating event. Patients may also experience swelling, temperature changes, color changes, sensitivity to touch, reduced mobility, and pain that feels disproportionate to the original injury.
For some patients with refractory CRPS, IV ketamine may be considered as part of a broader pain management plan. The evidence base for CRPS is stronger than it is for some other chronic pain conditions, but that does not mean results are predictable or permanent. Some patients may experience meaningful reduction in pain. Others may have partial or temporary benefit. Some may not respond.
At KDI Health, we discuss those possibilities clearly before treatment begins.
Fibromyalgia and Centralized Pain
Fibromyalgia is another condition we see in chronic pain conversations. It is typically associated with widespread pain, tenderness, fatigue, sleep disruption, cognitive symptoms sometimes described as “fibro fog,” and increased sensitivity to pain.
The rationale for ketamine in fibromyalgia is connected to pain processing and central sensitization, but the evidence is more limited and mixed than it is for CRPS. That distinction matters. We do not want patients with fibromyalgia to hear “ketamine may help pain” and assume that response is guaranteed or that one infusion will change everything.
For some patients, ketamine may be worth discussing when symptoms remain severe despite standard care. For others, it may not be the right fit. The decision depends on the full clinical picture, not the diagnosis alone.
Neuropathic Pain and Nerve-Related Pain Patterns
Neuropathic pain arises from damaged, irritated, or dysfunctional nerves. It may feel burning, shooting, electric, tingling, stabbing, or hypersensitive. Some patients experience pain after nerve injury, surgery, diabetes-related nerve damage, shingles, spine conditions, or other neurologic causes.
Ketamine’s NMDA receptor activity gives it a plausible role in selected neuropathic pain cases, especially when pain has become persistent and difficult to control. However, neuropathic pain is not one single condition. Different causes, patterns, medications, and medical histories can change whether ketamine is reasonable to consider.
That is why candidacy requires more than a symptom description. It requires a careful review of what has been diagnosed, what has already been tried, what medications the patient currently takes, and what other providers are already involved. For a deeper look at how chronic pain affects daily life, see our post on how chronic pain affects a person’s life.
Why Pain Management Care Is Required
At KDI Health, we accept chronic pain patients who are currently under the care of a pain management specialist.
That requirement is not a formality. Chronic pain patients often have complex, multidisciplinary needs that go beyond what a ketamine clinic alone can address. A pain management specialist can help confirm the diagnosis, guide the broader treatment plan, manage other medications or procedures, and help determine where ketamine may or may not fit.
We view IV ketamine as a potential addition to a broader care plan, not a replacement for comprehensive pain management. When patients give consent, collaboration with their existing care team can help make treatment safer, clearer, and better integrated.
If you are a Frisco or DFW area patient with chronic pain and are not currently working with a pain management physician or specialist, establishing that relationship should come before pursuing ketamine treatment for pain at KDI Health.
What We Review Before Recommending IV Ketamine
Not every patient with chronic pain is an appropriate candidate for IV ketamine.
Before making a recommendation, we review the patient’s pain diagnosis, treatment history, medical history, psychiatric history, current medications, cardiovascular status, and prior response to pain treatments. We also want to understand what the patient is hoping treatment will achieve. A realistic goal might be less pain, improved function, fewer flares, better sleep, or enough relief to participate more fully in physical therapy or daily life.
We also review whether the patient is actively established with a pain management specialist. That existing relationship is part of responsible chronic pain care, especially when a patient has multiple medications, prior procedures, imaging history, disability concerns, or overlapping mental health symptoms.
A ketamine consultation should clarify the role ketamine may play. It should not create the impression that ketamine replaces the rest of the patient’s pain care. You can review our ketamine therapy FAQs for answers to common questions before your first appointment.
What Treatment Looks Like in a Clinical Setting
At KDI Health, IV ketamine therapy is administered in a monitored clinical environment.
An IV line is placed, and ketamine is delivered directly into the bloodstream over a defined period. The IV route allows careful control over the infusion rate and dose during the session. Patients are monitored during treatment and observed afterward as the acute effects wear off.
During a ketamine infusion, patients may experience dissociation, changes in perception, dizziness, nausea, emotional intensity, or a dreamlike state. These effects are usually temporary, but they are medically meaningful. Patients should not drive themselves home after treatment and should plan for transportation and recovery time.
The exact treatment plan for chronic pain may differ from psychiatric protocols. Chronic pain protocols may involve different dosing, infusion length, series structure, or maintenance planning depending on the patient’s condition and response. These details should be discussed during consultation rather than assumed from a general article.
Cost, Insurance, and Practical Barriers
Cost is a real concern for many chronic pain patients.
KDI Health does not accept insurance plans, Medicare, Medicaid, or other insurance plans for ketamine treatment. Because ketamine for chronic pain is an off-label use, patients should expect out-of-pocket costs. Our team may be able to provide a superbill so patients can try to obtain reimbursement from their insurance company, but reimbursement is not guaranteed.
We accept HSA and FSA funds, and patients can ask our team about financing options through third-party financing resources. For patients who are already managing medical expenses from specialist visits, medications, imaging, procedures, therapy, and time away from work, these practical details matter.
We do not believe patients should be pressured into a treatment they do not understand. Cost, logistics, transportation, provider coordination, and recovery time all belong in the conversation.
Chronic Pain, Mood, and Quality of Life
Chronic pain affects more than the painful body part. It can change sleep, mood, relationships, work, concentration, movement, identity, and hope.
Many chronic pain patients also experience depression or anxiety. That overlap does not mean the pain is psychological. It means long-term pain and mental health often affect one another. When someone is in pain every day, it is not surprising that mood, stress tolerance, sleep, and energy may suffer.
Ketamine is studied in both pain and mood contexts, and some patients may notice changes in more than one area. Still, we are careful not to promise a dual benefit. Improvement in pain does not always mean improvement in mood, and improvement in mood does not always mean pain relief. Each patient’s response is individual.
Our goal is to understand the whole patient, not reduce the conversation to a pain score. For more on how ketamine has been used across pain and mood conditions in our region, read our post on the revolutionary impact of ketamine treatment in Frisco, TX for mood disorders and chronic pain.
Who May Be a Candidate?
A patient may be a candidate for IV ketamine for chronic pain if they have a clearly diagnosed chronic pain condition, are currently under the care of a pain management specialist, have not found adequate relief from standard treatments, can safely receive ketamine based on medical and psychiatric screening, and understand that the treatment is off-label with results that vary.
Patients with CRPS, fibromyalgia, neuropathic pain, or other refractory pain patterns may be appropriate for a consultation, especially when their symptoms remain disabling despite ongoing care.
A patient may not be a good candidate if medical risks, psychiatric risks, medication interactions, unstable health factors, lack of current pain management care, or unclear diagnosis make ketamine unsafe or inappropriate. That determination should be made through clinical evaluation, not self-screening.
If you are in Frisco or the broader DFW area, are currently working with a pain management specialist, and want to understand whether ketamine may fit into your chronic pain care plan, you can contact KDI Health to schedule a consultation.
Frequently Asked Questions
Is ketamine FDA-approved for chronic pain conditions like CRPS or fibromyalgia?
No. Ketamine is used off-label for chronic pain conditions such as CRPS, fibromyalgia, and neuropathic pain. Off-label use may be considered in selected patients, but it requires careful screening, informed consent, appropriate monitoring, and realistic discussion of the evidence.
Do I need to be under the care of a pain management specialist?
Yes. KDI Health accepts chronic pain patients who are currently under the care of a pain management specialist. A consultation can help clarify what documentation, medical history, or provider communication may be needed in your specific case. We view ketamine as a potential complement to broader pain care, not a replacement for a comprehensive pain management relationship.
How many infusions are typically needed for chronic pain?
Chronic pain protocols may differ from psychiatric protocols. They may involve different infusion lengths, dosing strategies, series structures, or maintenance discussions depending on the condition and the patient’s response. The appropriate plan is individualized and should be discussed during consultation.
Will ketamine interact with my current pain medications?
It might, depending on what you take and your medical history. Pain medications, psychiatric medications, sedatives, and other CNS-active medications all need to be reviewed before treatment. Do not stop, start, or adjust prescribed medications without speaking with the providers who manage them.
Can ketamine therapy for pain also help with co-occurring depression?
Some patients with chronic pain also live with depression or anxiety, and ketamine has been studied in both pain and mood disorders. Some patients may notice changes in mood during a treatment series, but this cannot be promised. We evaluate pain, mood, medications, and safety together because the whole clinical picture matters.
Key Takeaways
- Chronic pain can involve changes in how the nervous system processes pain, not just ongoing tissue injury.
- Ketamine’s NMDA receptor activity is one reason it is considered for some centrally mediated and refractory pain conditions.
- Ketamine for chronic pain is off-label and is not FDA-approved specifically for CRPS, fibromyalgia, neuropathic pain, or other chronic pain diagnoses.
- Evidence is strongest for selected CRPS cases and more limited or mixed for some other chronic pain conditions.
- KDI Health accepts chronic pain patients who are currently under the care of a pain management specialist.
- KDI Health evaluates candidacy through medical history, pain history, psychiatric history, medication review, safety screening, current pain management care, and realistic treatment goals.
- IV ketamine should be viewed as a potential part of a broader pain management plan, not a guaranteed cure or stand-alone replacement for ongoing care.
Conclusion
Chronic pain that has not responded to standard treatment is one of the most burdensome clinical challenges a patient can face. It affects the body, but it also affects sleep, work, mood, relationships, and daily life.
At KDI Health in Frisco, TX, we take that burden seriously. If you are dealing with CRPS, fibromyalgia, neuropathic pain, or another treatment-resistant pain condition, and you are currently under the care of a pain management specialist, IV ketamine may be worth discussing as part of a broader care plan.
The next step is not guessing whether you qualify. The next step is a careful consultation, an honest review of your history, and a clinically grounded conversation about whether ketamine is appropriate for you.
About Dr. Stephen Gasper
Dr. Stephen Gasper is the owner and medical director of KDI Health Ketamine Clinic, which he founded in early 2021 in Frisco, TX. At the age of 17, he enlisted in the Marines, serving four years as a forward observer in the infantry. He then moved to Texas and obtained his BS in Biology from the University of Dallas.
Dr. Gasper received his Medical Degree from UTHealth Houston in 2011 and practiced medicine in the DFW area for more than 10 years as a board-certified emergency physician. He was inspired to found KDI Health during the COVID pandemic because of the effectiveness of ketamine as a therapy adjunct for veterans and the broader community struggling with depression, anxiety, PTSD, and chronic pain.
At KDI Health, Dr. Gasper provides direct physician involvement throughout the ketamine care process.
Medical Disclaimer
The information provided in this blog is for educational purposes only and does not constitute medical advice. Treatment outcomes vary by individual. Please consult with a qualified healthcare provider before beginning any new treatment. Discuss with your provider whether ketamine therapy is appropriate for your specific medical and mental health history.
Works Cited
Cohen, S. P., Bhatia, A., Buvanendran, A., Schwenk, E. S., Wasan, A. D., Hurley, R. W., Viscusi, E. R., Narouze, S., Davis, F. N., Ritchie, E. C., Lubenow, T. R., Hooten, W. M., & Stojanovic, M. P. (2018). Consensus guidelines on the use of intravenous ketamine infusions for chronic pain management. Regional Anesthesia & Pain Medicine, 43(5), 521–546. https://pmc.ncbi.nlm.nih.gov/articles/PMC6023575/
Israel, J. E., St Pierre, S., Ellis, E., Miller, R., Southwick, S. M., Pietrzak, R. H., Harpaz-Rotem, I., & Krystal, J. H. (2021). Ketamine for the treatment of chronic pain. Frontiers in Pain Research, 2, 782183. https://pmc.ncbi.nlm.nih.gov/articles/PMC8567802/
National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2024). Fibromyalgia. U.S. Department of Health and Human Services, National Institutes of Health. https://www.niams.nih.gov/health-topics/fibromyalgia
National Institute of Neurological Disorders and Stroke. (2026). Complex regional pain syndrome. U.S. Department of Health and Human Services, National Institutes of Health. https://www.ninds.nih.gov/health-information/disorders/complex-regional-pain-syndrome
Rikard, S. M., Strahan, A. E., Schmit, K. M., & Guy, G. P., Jr. (2023). Chronic pain among adults — United States, 2019–2021. MMWR Morbidity and Mortality Weekly Report, 72(15), 379–385. https://www.cdc.gov/mmwr/volumes/72/wr/mm7215a1.htm
Tran, K., Argáez, C., & McCormack, S. (2023). Ketamine for chronic non-cancer pain: A 2023 update. Canadian Agency for Drugs and Technologies in Health. https://www.ncbi.nlm.nih.gov/books/NBK599849/
